DAT

DAT unveils DAT iQ Benchmark, an enhanced transportation rate and performance benchmarking tool for shippers

Retrieved on: 
Thursday, May 2, 2024
Software, Data Analytics, Artificial Intelligence, Professional Services, Technology, Logistics, Supply Chain Management, Transport, Business, Data science, Communication, Customer service, Data, Booth, Multimedia, DAT

DAT Freight & Analytics will introduce DAT iQ Benchmark™, a significant update to its transportation rate and data analytics service for shippers, at the 2024 Gartner® Supply Chain Symposium/Xpo™ in Orlando, Fla., from May 6-8.

Key Points: 
  • DAT Freight & Analytics will introduce DAT iQ Benchmark™, a significant update to its transportation rate and data analytics service for shippers, at the 2024 Gartner® Supply Chain Symposium/Xpo™ in Orlando, Fla., from May 6-8.
  • View the full release here: https://www.businesswire.com/news/home/20240502748268/en/
    DAT iQ Benchmark uses new AI-powered rate models trained on the industry’s largest dataset, comprising $150 billion in annual market transactions.
  • DAT iQ Benchmark data has been an invaluable source of truth.”
    Experience DAT iQ Benchmark at Booth 107 in the Logistics Solution Village.
  • Learn how reliable market-rate benchmarking delivers insights shippers need for better planning, performance evaluations, risk mitigation, network optimization, and cost management.

DAT Truckload Volume Index: March spot rates drop on modest volumes

Retrieved on: 
Tuesday, April 16, 2024
Professional Services, Trucking, Business, Data Analytics, Transport, Logistics, Supply Chain Management, Multimedia, DAT, TVI, Building material, Cargo

Spot truckload rates continued to slide in March as demand for trucking services moved toward typical seasonal levels, reported DAT Freight & Analytics, which operates the DAT One online freight marketplace and DAT iQ data analytics service.

Key Points: 
  • Spot truckload rates continued to slide in March as demand for trucking services moved toward typical seasonal levels, reported DAT Freight & Analytics, which operates the DAT One online freight marketplace and DAT iQ data analytics service.
  • “The decline in van and reefer spot rates coincided with the demand for truckload services picking up marginally toward the end of the month,” said Ken Adamo, Chief of Analytics, DAT Freight & Analytics.
  • Rates for contracted truckload freight declined for van and reefer freight.
  • The DAT iQ benchmark contract van and reefer rates dipped 3 cents to $2.48 and $2.86 a mile, respectively.

Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial

Retrieved on: 
Wednesday, March 13, 2024
Dopamine, NET, Reward, Sheba Medical Center, CWY, Psychiatry, Serotonin, Patient, Research, MEAI, Alcoholism, Clinical trial, DAT, Safety, Norepinephrine, Yale school, Therapy, Ministry, Pharmaceutical industry

The approval, previously announced on February 23, 2024, allows Clearmind to start its pioneering clinical trial.

Key Points: 
  • The approval, previously announced on February 23, 2024, allows Clearmind to start its pioneering clinical trial.
  • The clinical trial is a multinational, multi-center, single and multiple dose tolerability, safety and pharmacokinetic study of CMND-100 in healthy volunteers and AUD subjects.
  • The Clearmind team has been working tirelessly on the research and development of a novel treatment to the global epidemic of alcoholism.
  • We are eager to continue our work with patients in need of help,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.

Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Retrieved on: 
Friday, February 23, 2024
Therapy, Reward, Alcoholism, Ministry, NET, Serotonin, Dopamine, Norepinephrine, Safety, MEAI, CWY, Patient, Clinical trial, Yale school, DAT, Psychiatry, Sheba Medical Center, Research, Pharmaceutical industry

Vancouver, Canada, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce it has received approval from the Ministry of Health of Israel to commence its phase I/IIa clinical trial for alcohol use disorder (AUD) patients using the company's proprietary MEAI-based (5-methoxy-2-aminoindane) CMND-100 oral capsule.

Key Points: 
  • "We are thrilled to receive approval to commence our phase I/IIa clinical trial for our lead drug candidate, CMND-100, which has been shown to be safe and effective in preclinical studies.
  • This is the most important milestone for the company to date and marks our transition to a clinical- stage pharmaceutical company.
  • The Clearmind team has been working tirelessly on the research and development of a novel treatment to the global epidemic of alcoholism.
  • We are eager to continue our work with patients in need of help,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.

EQS-News: The new Porsche Taycan: improved in almost every discipline

Retrieved on: 
Tuesday, February 6, 2024
Pulse, WLTP, CarPlay, Acceleration, SOC, CO2, Porsche Design, System, PS, News, HD, Tail, DAT, Standstill, Software, Rail transport

Recuperation increased to up to 400 kW at high speeds

Key Points: 
  • Recuperation increased to up to 400 kW at high speeds
    Faster: Acceleration from 0 to 100 km/h is up to 0.6 seconds faster.
  • All Taycan versions feature an even more extensive standard equipment list and come with the latest generation of the Porsche Driver Experience with an improved display and control concept.
  • The revised versions will arrive at Porsche Centres from the spring of 2024.
  • In addition to the upgraded equipment, the improved product specification includes a battery with increased capacity but with a reduced weight.

Verosint Empowers DAT Freight & Analytics To Crush Account Fraud With AI

Retrieved on: 
Tuesday, February 6, 2024
Technology, Finance, Security, Transport, Banking, Professional Services, Software, Logistics, Supply Chain Management, Artificial Intelligence, Multimedia, Fraud, API, DAT, Conference, Movement, Audit

Verosint , a leader in real-time account fraud prevention, has been selected by DAT Freight & Analytics to combat account fraud within their online freight marketplace.

Key Points: 
  • Verosint , a leader in real-time account fraud prevention, has been selected by DAT Freight & Analytics to combat account fraud within their online freight marketplace.
  • Verosint will also provide live demonstrations of their account fraud prevention solution at the Manifest 2024 Conference from February 5th to 7th at Booth K19.
  • Verosint helped us identify fraud clusters and trends across our vast event data,” said Calvin Locklear, Enterprise Solutions Product Manager, DAT Freight & Analytics.
  • The webinar will also cover best practices to outsmart persistent fraudsters with industry experts from DAT, Verosint, Okta and IDdataweb.

EQS-News: Macan sets new standards: the first all-electric SUV from Porsche

Retrieved on: 
Tuesday, January 30, 2024
PASM, CO2, Porsche Macan, Headlamp, PPE, PS, VAT, Traction, Lightning, SUV, DNA, PCM, HV, Air conditioning, Electronics, IPB, AC, LED, DAT, Carbon, News, PSM, 3D, Android Automotive, PAA, Light, Human, Turbocharger, Electric motor

Ten years after its launch, the Porsche Macan is heading into its second model generation, now in all-electric form.

Key Points: 
  • Ten years after its launch, the Porsche Macan is heading into its second model generation, now in all-electric form.
  • Through its progressive, timeless design, characteristic Porsche performance, long-distance range and high everyday practicality, the new Macan 4 and the new Macan Turbo aim to completely fulfil the requirements of Porsche customers choosing an SUV.
  • The Macan 4 accelerates from a standstill to 100 km/h in 5.2 seconds, while the Macan Turbo takes just 3.3 seconds.
  • Porsche developed the Macan with a keen focus on quintessential Porsche driving dynamics and a characteristic steering feel.

DAT strengthens leadership team with two key executive appointments, furthering its commitment to innovation and information security

Retrieved on: 
Thursday, January 18, 2024
Software, Networks, Professional Services, Internet, Data Management, Technology, Artificial Intelligence, Security, Other Transport, Data Analytics, Trucking, Transport, Logistics, Supply Chain Management, Shift, High tech, Platform as a service, Research, PayPal, Multimedia, Culture, Marketplace, Software as a service, AI, Capital One, Walmart, Information security, DAT, Fraud, Lead, Salesforce, Doctor of Philosophy, Machine learning, Engineering, Intel, Infrastructure as a service, Information, Management

View the full release here: https://www.businesswire.com/news/home/20240118229744/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240118229744/en/
    Jeff Clementz, DAT Chief Product Officer (Photo: DAT Freight & Analytics)
    Jeff Clementz has 25 years of experience and joined DAT as Chief Product Officer and a member of the executive team.
  • Jeff most recently was president and chief executive officer at Shift, an e-commerce platform for the auto industry.
  • Erika held information security leadership positions at Salesforce and Oracle, where she was responsible for SaaS, PaaS and IaaS security and compliance.
  • “I’m excited to have Erika join DAT and lead our information security initiatives to ensure that DAT delivers the most trusted marketplace for freight.”

Clearmind Medicine Completed Type A Meeting with the FDA

Retrieved on: 
Wednesday, January 10, 2024
MEAI, CWY, Serotonin, DAT, Reward, NET, IND, Food, Dopamine, FDA, Therapy, Norepinephrine, Pharmaceutical industry

"We're pleased to report we recently met with the FDA to align on the content of our IND resubmission for CMND-100," said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.

Key Points: 
  • "We're pleased to report we recently met with the FDA to align on the content of our IND resubmission for CMND-100," said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.
  • The active ingredient in CMND-100 is MEAI (5-methoxy-2-aminoindane), a novel psychoactive molecule that has been reported to reduce the desire to consume alcoholic beverages while exerting a euphoric alcohol-like experience.
  • MEAI was found to interact with the serotonergic receptors 5-HT1a, 5-HT2a and 5-HT2b.
  • The serotonergic system is considered to play a key role in the regulation of alcohol intake, reward, preference, and dependence.

Alipay+ and Partner E-Wallets Drive Sustainable Travel in Year-End Global Campaign

Retrieved on: 
Thursday, December 14, 2023
Retail, Technology, Finance, Fintech, Other Travel, Transportation, Apps, Applications, Professional Services, Destinations, Travel, Other Retail, Personal Finance, Vacation, Payments, Mobile, Wireless, King Power, Sustainable Development Goals, Mom, GCash, Tourism, Somatosensory system, Chinese, BNPL, CUHK, Multimedia, Culture, University of Geneva, Ecosystem, SME, TrueMoney, Marketing, Merchant services, Digital, Tsinghua University, University, DAT, TPV, HK, Naukri.com, KakaoPay, Northwestern University in Qatar, ESG, Cryptocurrency, Online shopping, Tutoring, Alipay, University of Hong Kong

Ant International is committed to promoting sustainable and responsible tourism across its Alipay+ markets, with an ESG program closely aligned with the UN Sustainable Development Goals (SDGs).

Key Points: 
  • Ant International is committed to promoting sustainable and responsible tourism across its Alipay+ markets, with an ESG program closely aligned with the UN Sustainable Development Goals (SDGs).
  • The campaign features special offers from Alipay+ and partners to encourage sustainable travel behavior, such as free overseas mobile data packages, in-app discounts across Alipay+’s extensive merchant network, and opportunities to win 100% rebates at partner stores.
  • Dr Cherry Huang, General Manager of Alipay+ Offline Merchant Services, Ant International said, “Our year-end campaign is not just about travel; it’s about making a positive impact.
  • Touch ’n Go eWallet cross-border payments in the Chinese mainland have grown by more than 100% month-on-month in 2023.